SARS-CoV-2 (2019-nCoV) envelope(CoV-E) protein (C40A, C43A, C44A)-His & MBP Recombinant Protein: Product Information
> 90 % as determined by SDS-PAGE.
Please contact us for more information.
Testing in progress
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) E(C40A, C43A, C44A)-His & MBP Recombinant Protein (YP_009724392.1) (Met1-Val75(C40A, C43A, C44A)) was expressed with a N-terminal polyhistidine-tagged MBP tag at the N-terminus (his-MBP).
Predicted N Terminal
The recombinant SARS-CoV-2 (2019-nCoV) E(C40A, C43A, C44A)-His & MBP Recombinant Protein consists of 475 amino acids and predicts a molecular mass of 52.2 kDa.
Lyophilized from sterile PBS, pH 7.4. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃ Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
Successfully added to cart Please enter catalog numberSubmitted successfullyNetwork ErrorPlease enter your company namePlease enter your namePlease enter your emailPlease enter a valid email addressPlease enter some messageNot found.